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ABSTRACT
International Journal of Exercise Science 12(3): 1023-1033, 2019. Although cognitive dysfunction is a
common occurrence among breast cancer survivors, there is no widely recognized intervention for this
debilitating condition. The purpose of this study was to determine whether floor/step aerobics (FSA) and/or
treadmill walking (TMW) interventions can improve outcomes when compared to standard care (STC). Recent
breast cancer survivors participated in 12 weeks of FSA (n=8), TMW (n=7), or STC (n=10) with pre/post
assessments of cognition and fitness. Interaction effects between group and time were assessed with repeated
measures ANOVA. Throughout the extent of cognitive and fitness assessments, there were found to be no
statistically significant interactions between group and time. Because of the small sample size, these results
should not be taken to mean that exercise cannot improve cognition in recent breast cancer survivors, but this
study should be used as a baseline for designing similar studies with a longer intervention, more intense exercise
program, or another alteration that might increase effectiveness of the intervention. More research is needed in
this area, but until more specific study results are available, healthcare providers should continue to encourage
breast cancer survivors to regularly participate in aerobic exercise to maintain physical function.
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INTRODUCTION
An estimated 65% of breast cancer survivors suffer from dysfunction in a variety of cognitive
domains (23), as described by the term “cancer-induced cognitive dysfunction” (CICD).
Although cognition improves over time in many women, researchers have demonstrated that
some breast cancer survivors who are 20 years post-treatment still score lower on
neuropsychological assessments of verbal learning, executive function, and psychomotor
function than do their age-matched counterparts (12). Other cognitive domains that are
commonly hindered in this population include memory, processing speed, and attention. In
general terms, breast cancer survivors often describe their symptoms as a change in memory,
fogginess in the brain, difficulty focusing, decreased ability to follow directions, and trouble
with multitasking (16). Because of their effect on daily tasks, these symptoms are likely to
reduce quality of life in breast cancer survivors.
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In accordance with the International Cognition and Cancer Task Force (ICCTF) guidelines (24),
some researchers report the percentage of their participants who experienced objective
cognitive decline from pre-treatment to post-treatment, rather than only reporting statistical
data. By using the Mini-Mental State Exam to determine cognitive ability, Biglia and
colleagues found that the number of breast cancer survivors (n = 40) who scored below the
mean increased from 19.5% before treatment to 30.8% immediately post-treatment (4), which
indicates that treatment for breast cancer decreases basic cognitive functions in a subset of
survivors. Debess and colleagues found that 15.4% of their 120 breast cancer survivor
participants demonstrated cognitive decline on at least two tests (5), which was considered to
be a clinically significant decline. Vearncombe and colleagues reported that 16.9% of their 136
breast cancer survivor participants had significant cognitive decline post-chemotherapy (21).
Stewart and colleagues found that 31% of their 61 patients who were treated with
chemotherapy showed reliable cognitive decline, while only 5% showed reliable improvement
(20). These studies show that one sixth to one third of breast cancer survivors appear to suffer
from clinically significant cognitive decline. However, since there are more than 3.5 million
breast cancer survivors alive today (1), it could be extrapolated that ½ million to 1 million
women in the United States alone have previously, or are currently, suffering from CICD.
While it seems that treatment for breast cancer does not adversely impact cognition in all
breast cancer survivors, there is enough evidence that it can significantly negatively impact
many cognitive domains in a large number of women. Based on this evidence, it is important
to consider whether interventions could reduce CICD to improve quality of life in those breast
cancer survivors who are affected by this disorder.
Chemotherapy-induced cognitive dysfunction can be reduced in rats by regular participation
in physical activity. In a study by Fardell and colleagues, healthy adult rats were treated with a
chemotherapy regimen that is known to cause cognitive dysfunction (8). Their control group
remained sedentary while the intervention group was provided with access to a running
wheel for four weeks. After this time, the physically active rats scored significantly higher than
their sedentary counterparts on spatial reference memory and novel object recognition tests (p
< .05). These results provide support for conducting a similar study with humans to determine
if aerobic exercise is an effective intervention for reducing CICD. However, a recent Cochrane
review reported that there is a substantial lack of conclusive data from well-designed,
adequately sized studies regarding the impact of aerobic exercise on cognitive function in
breast cancer survivors (9).
In another study, 41 breast cancer survivors completed 12 weeks of cognitive training or a
wait-list control period (11). Those in the intervention group had significantly improved postintervention scores in the Wisconsin Card Sorting Test (p = .008), letter fluency (p = .003), and
the symbol search test (p = .009), demonstrating the effectiveness of cognitive training in this
population. A cognitively challenging exercise intervention could potentially function
similarly to a cognitive training program, enhancing cognition while also increasing
cardiorespiratory fitness.
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The aforementioned studies demonstrate that aerobic exercise and cognitive training both
have the potential to improve cognitive function in breast cancer survivors. However,
published research does not indicate whether there are additional benefits from combining
these interventions.
The primary purpose of this study was to determine whether aerobic exercise improves
cognition in recent breast cancer survivors compared to a sedentary lifestyle or standard care
(STC), and to identify whether floor/step aerobics (FSA) improves cognition more than does
treadmill walking (TMW). FSA involves following frequently changing upper and lower body
movement patterns from verbal cues by a group exercise leader, which adds a cognitive
stimulus to the exercise program when compared to treadmill walking monotonously in a
straight line. The secondary purpose of this study was to compare effects of FSA, TMW, and
STC on cardiorespiratory fitness among breast cancer survivors to ensure that fitness benefits
of aerobic exercise participation are maintained when a cognitive stimulus is added.
METHODS
Participants
Participants were female, with a mean age of 60 years old, who reported being sedentary at
enrollment. Study inclusion criteria required that they be within 3 months following
completion of primary treatment for breast cancer. Ongoing treatments, such as tamoxifen and
Herceptin, were allowed. Exclusion criteria included current pregnancy, participation in a
concurrent exercise program, reconstructive surgery or surgery rehabilitation during the
study, inability to obtain medical clearance, and inability to speak English fluently. The study
design was approved by the Institutional Review Board at Washington State University (WSU)
before recruitment began.
Effect sizes are not readily available for exercise interventions on cognition among recent
breast cancer survivors. Among adults, in general, the effect size of exercise on cognitive
function is approximately 0.30 (3). Therefore, a power analysis demonstrated that 30 women
were needed for this study, with 10 assigned to each group, in order to distinguish interaction
effects. Within the allotted time frame, 25 women gave informed consent to participate and
completed the study. Assessed subject characteristics did not differ significantly between
groups at baseline (see Table 1).
Table 1. Participant demographics. Shown as mean ± standard deviation.
FSA (n=8)
TMW (n=7)
Age
60.38 ± 10.07
58.71 ± 6.99
Education
15.38 ± 1.19
14.86 ± 2.55
Resting Heart Rate
71.67 ± 12.35
68.14 ± 7.47
Systolic Blood Pressure
122.67 ± 15.13
111.14 ± 11.13
Body Mass Index
31.24 ± 8.19
29.89 ± 7.15
Percent Body Fat
40.00 ± 6.17
39.77 ± 5.82
Timed Up & Go
8.28 ± 1.54
8.88 ± 1.05
Perceived Stress Scale
14.56 ± 7.54
11.29 ± 6.07
FSA: Floor/step aerobics, TMW: Treadmill walking, STC: Standard care.
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STC (n=10)
60.82 ± 11.54
14.40 ± 3.66
72.15 ± 9.37
125.54 ± 17.01
29.23 ± 6.32
39.67 ± 7.09
9.17 ± 1.88
14.38 ± 5.68

p-value
0.908
0.275
0.680
0.144
0.809
0.993
0.485
0.528
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Protocol
All participants who met inclusion and exclusion criteria were enrolled into the study in one of
three groups: FSA, TMW, or STC. They were assigned to a group based on the class time that
they selected. To reduce the risk of home-based exercise as a confounding variable, all
participants were asked to maintain their normal level of physical activity, except for attending
designated exercise classes at the study site. Participants were asked to complete and return an
exercise log to confirm their offsite physical activity.
Women in the STC group were instructed to remain sedentary throughout the study, but were
invited to attend 12 weeks of free exercise classes following post-testing as an incentive to
submit exercise logs and complete post-testing. TMW and FSA participants attended exercise
classes for 12 weeks at WSU’s Health Sciences Campus. The exercise prescription (frequency,
intensity, time, and type) was based on the American College of Sports Medicine
recommendations for this population (2): 30-50 minutes, three to five days per week of
moderately intense aerobic exercise that uses large muscle groups.
Frequency: Breast cancer survivors attended classes each Monday, Wednesday, and Thursday.
Participants were allowed to miss three exercise classes; additional missed class days were
required to be rescheduled. Intensity: All classes were held at a moderate intensity, which was
monitored throughout class using heart rate (HR) and Borg’s ratings of perceived exertion
(RPE) scale (7) in which exertion is rated between 6 and 20. Moderate intensity is classified as
an RPE of 12-13 or HR of 40%-<60% of heart rate reserve (2). If exercising HR or RPE were not
in the desired range at any checkpoint, participants were assisted with making modifications
to intensity. Time: Exercise classes were 50 minutes long to allow participants to utilize the free
one-hour parking on campus. By scheduling three classes per week, this duration also met the
minimum national recommendations for weekly physical activity volume (2). Type:
Participants were assigned to FSA or TMW classes for the duration of the study. The first half
of each FSA class focused on step aerobics, and the second half of each class focused on floor
aerobics. A single instructor designed and taught all classes using a standard 32-count design.
In this format, movements are organized into 32-count blocks that are gradually learned
throughout the session and then repeated until the class can perform them without any
instructor cues. TMW classes began with a slower walk at an incline and concluded with a
rapid walk with no incline, mimicking the speed and grade changes in the FSA classes.
Treadmill speeds varied between individuals, but were set at a level that kept heart rates
within the goal range.
Data was collected during a separate testing appointment the week prior to and the week
following the 12-week intervention, on non-exercise days, to reduce risk of a false positive
cognitive improvement from acute exercise. To prepare for test days, participants were
instructed to maintain their normal activities and intake, and to avoid products containing
alcohol, caffeine, or tobacco. Assessments were conducted at a standard room temperature and
humidity. A thorough explanation of test procedures was given prior to each test. Where
standard protocols indicate, a demonstration or practice test were also given.
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Cognition was assessed using a battery of traditional cognitive assessments to test all primary
cognitive domains. The Trail Making Test-A (TMT-A) and Trail Making Test-B (TMT-B) (14)
involve participants connecting numbered dots as quickly as possible, and rapidly alternating
between numbered and lettered dots, respectively. TMT-A is an assessment of attention and
processing speed; TMT-B assesses executive function. The Controlled Oral Word Association
Tests (COWAT) (including FAS, category, and switching trials) (14) require participants to
name as many words as possible, within certain criteria, in one minute. These assessments
show verbal fluency. Design Fluency (DF) tests involve participants drawing a variety of
shapes by connecting dots, also within one minute. Condition 1 involves connecting black
dots, Condition 2 involves connecting white dots, and Condition 3 involves alternating
between black and white dots. Conditions 1 and 2 assess attention and processing speed, while
Condition 3 assesses executive function. The Grooved Pegboard Test (GPT) requires
participants to place odd shaped pegs into a pegboard as quickly as possible, which shows
psychomotor function. This was selected as a control test; results should not change with an
exercise intervention. In order to determine cardiorespiratory fitness for exercise prescription,
as well as to assess improvement following the intervention, fitness was estimated using the
Ebbeling Submaximal Single-Stage Treadmill Walking Test (15, 22). In this test, participants
walk on a treadmill at a self-selected speed and a 5% grade for four minutes, at which point
exercising heart rate is assessed. Maximal VO2 was predicting using the standard Ebbeling
equation, which uses age, gender, walking speed, and exercising heart rate as variables. Based
on previous experience (13) treadmill speed was held constant during pre- and post-testing,
leaving exercising HR as the only test variable between tests.
Statistical Analysis
Repeated measures analysis of variance (SPSS 23) indicated whether there was an interaction
between group and time. Assessments were considered statistically significant if the
interaction p-value was less than or equal to .05. All data is reported as mean ± standard
deviation.
RESULTS
Trail Making Tests: The statistical interaction between group and time for the TMT-A test was
not significant (FSA: 26.00±6.17, 22.11±7.28; TMW: 25.08±9.36, 22.05±4.50; STC: 27.13±7.72,
26.21±9.18; p = .637). Results are shown in Figure 1. The TMT-B also showed no interaction
between group and time (FSA: 62.58±8.95, 51.77±15.46; TMW: 58.77±24.32, 57.79±22.70; STC:
57.36±16.34, 48.54±16.51; p = .292).
Verbal Fluency: There was no significant interaction of exercise group over time on verbal
fluency scores when measured with the FAS test (FSA: 11.75±3.62, 13.69±3.51, TMW:
13.57±4.50, 14.14±3.93, STC: 11.57±2.23, 10.86±4.02; p = .296), as shown in Figure 2, with the
“category” trials (FSA: 44.00±11.77, 48.63±11.56; TMW: 42.00±12.65, 45.57±11.69; STC:
36.20±7.24, 37.80±10.02; p = .662), or with the “switching” trial (FSA: 15.13±2.42, 14.00±2.39;
TMW: 15.00±3.27, 16.43±3.21; STC: 13.10±2.56, 13.70±4.50; p = .369).
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Figure 1. Effect of exercise modality over time on attention and processing speed during the TMT-A.

Figure 2. Effect of exercise modality over time on verbal fluency.
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Design Fluency: When assessing results from the DF test, it is standard to add scaled scores
from Condition 1 and Condition 2, and then scale that sum. Using this procedure, the
interaction between group and time on DF results was not statistically significant (FSA:
12.75±3.69, 14.25±2.25; TMW: 11.71±2.63, 14.29±3.86; STC: 11.67±3.43, 12.00±2.74; p = .261). It is
standard to also scale the sum of scaled scores from all three conditions. Results from this
calculation were also insignificant (FSA: 12.63±3.70, 14.13±2.53; TMW: 12.00±2.52, 13.43±3.74;
STC: 12.11±3.33, 12.67±3.32; p = .624). This is shown in Figure 3.

Figure 3. Effect of exercise modality over time on design fluency.

Grooved Pegboard: There was very little change in scores, and no interaction between group
and time on the speed of test completion for the dominant hand (FSA: 77.07±13.29, 77.58±9.94;
TMW: 62.88±8.05, 61.10±9.78; STC: 73.61±15.60, 70.02±11.51; p = .602) or the non-dominant
hand (FSA: 76.02±9.36, 78.26±12.52; TMW: 78.72±7.01, 78.90±16.03; STC: 76.34±17.15,
79.79±20.39; p = .863), indicating that exercise modality has little to no impact on psychomotor
function.
Fitness: Exercising heart rate decreased slightly following participation in the FSA and TMW
interventions, whereas 12-weeks of STC resulted in an increased exercising heart rate.
However, this did not result in a significant interaction between group and time (FSA:
113.94±20.76, 108.25±22.94; TMW: 113.33±9.84, 102.58±10.81; STC: 105.36±12.84, 109.21±14.65; p
= .101), indicating that intervention group assignment did not have a statistically significant
effect on exercising heart rate, but demonstrating a potentially clinically important
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improvement in cardiorespiratory fitness with either type of exercise. The percent of change in
these results is shown in Figure 4 (p = .093).

Figure 4. Effect of exercise modality on exercising heart rate at a constant intensity.

DISCUSSION
There was a significant interaction between group and time on TMT-A results (p = .011) in our
similarly designed previous study of healthy women (13), indicating that FSA can be more
effective than TMW at improving attention and processing speed in healthy women. Among
breast cancer survivors, both FSA and TMW improved TMT-A results to a slightly greater,
though not significant extent, compared to STC. It is possible that the small sample size
prevented significant findings. It is also possible that the intervention was not rigorous enough
to result in significant improvements.
Researchers have shown that verbal fluency can be diminished in breast cancer survivors
following treatment (10, 18). Our intervention did not result in significant improvements in
verbal fluency using COWAT assessments. While exercise was expected to improve brain
function, it is possible that physical movement does not improve verbal abilities.
It was expected that executive function would increase to the greatest extent in FSA
participants due to the nature of this modality, which requires multi-tasking processes in the
brain. However, there was no indication of improvement in any group on the TMT-B or
switching trial of verbal fluency, which were the two assessments of executive function. This
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indicates that 12 weeks of structured aerobic exercise might not be sufficient to significantly
improve executive function in recent breast cancer survivors. Rehabilitating executive function
might also require more complex cognitive tasks than can be provided from an exercise
modality. Interestingly, however, Ehlers et al. recently reported that breast cancer survivors
who were more physically active, as measured by minutes of moderate-to-vigorous activity
per day, had higher executive function than those who were less active, indicating that an
active lifestyle might be as important as a structured exercise program (6).
Similar to executive function, the interventions did not appear to have any impact on
assessments of psychomotor function. Since psychomotor function was not directly challenged
during the interventions, this was expected.
Both exercise intervention groups had a decreased average exercising heart rate, with intensity
held constant, during post-testing as compared to pre-testing. While this change was not
statistically significant, it could be clinically significant if it was correlated with improvements
in cardiorespiratory fitness. A decreased exercising heart rate with aerobic training is
consistent with the literature (17) and demonstrates that the women assigned to FSA did not
significantly reduce their fitness benefits, compared to those using a treadmill, by adding
multi-directional, cognitively stimulating movements.
The greatest limitation to this study was that it took more than 2 years to enroll 25 recent
breast cancer survivors who completed the intervention and post-testing. Due to the extreme
difficulty in recruitment, it was recommended that the study be closed before the target
sample size of 30 was obtained, which increases the risk of type II errors. Directly correlated
with the inadequate sample size was the inability to fully randomize participants. In an effort
to get enough women who could participate in the study, consideration was given to class
time preference, but not modality preference, when determining group assignment. Even so,
classes did not have the recommended number of eight women for group dynamics (19).
Future studies should focus on determining an exercise intervention to improve each domain
of cognitive function among breast cancer survivors. Manipulation of intensity, duration, and
frequency of each session could result in greater cognitive effects than were shown in this
study. Strategies addressing muscular strength, endurance, and flexibility in a well-controlled
cognitive intervention are also warranted. Additionally, research with cancer survivors should
be conducted in collaboration with local oncologists who can refer all eligible patients and
encourage participation. Finally, screening for subjective or objective cognitive dysfunction
prior to enrollment would allow for greater benefits to be seen from an intervention.
Although results were inconclusive, this study still provides some of the most specific
information available regarding aerobic exercise modality for cognitive improvement among
recent breast cancer survivors. In conjunction with previous research demonstrating the health
benefits of exercise for cancer survivors and past studies showing cognitive improvement with
exercise, this study demonstrates the need for more research in this area.
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Participation in aerobic exercise has long been encouraged for health promotion and chronic
disease prevention. It has previously been shown to be a safe and effective means for cancer
survivors to reduce various cancer-related side effects. Until new studies provide further
evidence, healthcare providers should encourage recent breast cancer survivors who suffer
from CICD to participate in 150 minutes per week of a moderately intense aerobic exercise
program.
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